At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 198 enrolled
Drug / intervention
Aspirin +3 moredrug
Likely dose
Clopidogrel 75mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Dual-Antiplatelet and Triple-Antiplatelet Preparation Using P2Y12 Assay in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for An Unruptured Intracranial Aneurysm
In Brief
A Phase 4 clinical trial evaluating Aspirin, Prasugrel, and 2 other interventions for Aneurysm, Cerebral and Endovascular Procedures. Completed, enrolled 198 participants across 1 site.
Detailed Summary
Perform a randomized comparison study of dual-antiplatelet (aspirin, prasugrel) and triple-antiplatelet (aspirin, clopidogrel, and cilostazol) preparation using P2Y12 assay in patients with high on-treatment platelet reactivity undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAneurysm, Cerebral, Endovascular Procedures
CountriesSouth Korea
CollaboratorsSeoul National University Bundang Hospital
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartOct 2018
Primary CompletionJan 2021
TodayJul 2026
First PostedJul 10, 2018
Enrollment StartOct 24, 2018
Primary CompletionJan 22, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.0 years ago
Interventions
Aspirindrug
Aspirin protect tablet
Prasugreldrug
Prasugrel tablet
Clopidogreldrug
Clopidogrel 75mg tablet
Cilostazoldrug
Cilostazol tablet